Marginal Zone Lymphoma
What's New
Last Posted: Nov 02, 2024
- Clinicopathological characteristics and genomic profiling in patients with transformed lymphoma: a monocentric retrospective study.
Xia Zhao, et al. Annals of medicine 2024 0 (1) 2419556 - Two cases demonstrate an association between Tropheryma whipplei and pulmonary marginal zone lymphoma.
J D Haslbauer, et al. Infectious agents and cancer 2024 0 (1) 33 - Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
Francesca Castellani, et al. Neurology(R) neuroimmunology & neuroinflammation 2023 0 (4) - Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
Tatarczuch Maciej, et al. Blood advances 2023 0 - Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.
Jallades Laurent, et al. Haematologica 2017 0 (10) 1758-1766 - Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.
Hyeon Jiyeon, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018 0 (9) 1418-1428 - Dural Extranodal Marginal Zone Lymphoma in an XRCC2 Mutation Carrier.
Gvozdjan Kristina, et al. Journal of neuropathology and experimental neurology 2019 0 (12) 1174-1177 - Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.
Jaramillo Oquendo Carolina, et al. Scientific reports 2019 0 (1) 10444 - A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
Varettoni Marzia, et al. British journal of haematology 2019 0 (4) 441-446 - Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
Gailllard Baptiste, et al. British journal of haematology 2020 0 (1) 72-82 - Thyroid MALT lymphoma: self-harm to gain potential T-cell help.
Wu Fangtian, et al. Leukemia 2021 0 (12) 3497-3508 - Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features.
Lim Sojung, et al. The American journal of surgical pathology 2022 0 (10) 1397-1406 - Analysis of Genetic Alterations in Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma With Whole-Exome Sequencing.
Zhao Andi, et al. Frontiers in oncology 2022 0 817635 - Identification of a Cancer-Predisposing Germline POT1 p.Ile49Metfs*7 Variant by Targeted Sequencing of a Splenic Marginal Zone Lymphoma.
Jajosky Audrey N, et al. Genes 2022 0 (4) - The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.
Magistri Marco, et al. Cancer research communications 2022 0 (1) 1-16 - Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin Isaias, et al. International journal of molecular sciences 2020 0 (1) - Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome.
Bult Johanna A A, et al. Cancers 2022 0 (4) - Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma.
Wu Xiao-Bo, et al. Frontiers in oncology 2022 0 901547 - B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Wang Sophia S, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 2 - Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.
Noy Ariela, et al. Blood advances 2020 11 (22) 5773-5784
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: